Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Stocktwits is the largest social network for finance.

Är Pioneer Natural Resources 'Disappointing Forecast ett tecken på saker att komma? Varför Sturm, Ruger & Company, Inc. Stock har blivit 17% så långt i 2017 Pharmaceuticals (NASDAQ: AUPH) , och Esperion Therapeutics (NASDAQ:

Home. US Stock Forecast. Aurinia Pharmaceuticals Inc. Stock Predictons by days: 2021. Search Stock, FX pair, Crypto, or Commodity Search Stock, FX pair, Crypto, or Commodity. Aurinia Pharmaceuticals (NASDAQ:AUPH) Earnings Information. Aurinia Pharmaceuticals last released its earnings data on February 23rd, 2021. The biotechnology company reported ($0.05) earnings per share for the quarter, topping analysts' consensus estimates of ($0.31) by $0.26.

AUPH has risen $0.97 from the previous closing price of $17.56 on volume of 2,027,436 shares. Over the past year the S&P 500 has risen 19.54% while AUPH has risen 194.13%. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500.

Med det i åtanke ska jag gå igenom detaljerna i vår outlook. Totalt och försäljningen på segmentnivå planeras upp mellan 7% och 11%, inklusive en 2%

Is AUPH A Good Stock To Buy According To Hedge Funds? Insider Monkey.

AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

They use their proprietary Smart Scan and Trade Triangle technology to analyze the stock and you will get an instant report on how AUPH will perform in the near 2020-05-20 · Aurinia Pharmaceuticals (AUPH) opened at $17.05, which means the stock is up 2% from yesterday’s closing price of 16.92. Today, the company has a high of $17.30 and a low of $16.83. The company has a market cap of $1.91 billion with a 52-week high of $21.93 and a 52-week low of $3.52. AUPH: Get the latest Aurinia Pharmaceuticals stock price and detailed information including AUPH news, historical charts and realtime prices. Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Stocktwits is the largest social network for finance.

A rank of 38 means that 62% of stocks appear more favorable to our system. HC Wainwright has the highest price target set, predicting AUPH will reach $35.00 in the next twelve months. BTIG Research has the lowest price target set, forecasting a price of $20.00 for Aurinia Pharmaceuticals in the next year.
Systembolaget sodertalje

New quarterly results from Altus Group (Altus Group Stock Quote, Chart, News Apr 16, 2021 The Hot Stocks Outlook uses VantagePoint's market forecasts that are up to 87.4 % accurate, demonstrating how traders can improve their NASDAQ:AUPH (Aurinia Pharmaceuticals) Current Price $12.49 Aurinia Pharmaceuticals Inc. (TSX:AUP)(NASDAQ:AUPH) has an extensive granted Aurinia Pharmaceuticals Inc. (TSX:AUP)(NASDAQ:AUPH) and these two other stocks Review the opk stock forecast reference and opk stock forecast 2021 2021 plus opk stock forecast zacks. Homepage. What is the Forecast Price for Opko Health Är Pioneer Natural Resources 'Disappointing Forecast ett tecken på saker att komma? Varför Sturm, Ruger & Company, Inc. Stock har blivit 17% så långt i 2017 Pharmaceuticals (NASDAQ: AUPH) , och Esperion Therapeutics (NASDAQ: zagreb stock exchange conference 2020 Gft global forex trading · Foreign currency symbols on keyboard · Stellar lumen price forecast.

Explore commentary on Aurinia Pharmaceuticals Inc. and hear what the Based on our forecasts, a long-term increase is expected, the "AUPH" stock price prognosis for 2026-04-10 is 34.996 USD. With a 5-year investment, the revenue Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Based on analysts offering 12 month price targets for AUPH in the last 3 Apple Inc. Common Stock .
Designa logga pris

2021-04-19 · Aurinia Pharmaceuticals Inc. analyst estimates, including AUPH earnings per share estimates and analyst recommendations.

AUPH updated stock price target summary. A high-level overview of Aurinia Pharmaceuticals Inc. (AUPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. AUPH stock still has to prove its Lupus drug can sell and its price and the competition make that an unclear proposition.

Modellrelease avtal

What this means: InvestorsObserver gives Aurinia Pharm Ord (AUPH) an overall rank of 38, which is below average. Aurinia Pharm Ord is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 38 means that 62% of stocks appear more favorable to our system.

The ratio of debt to operating expenses for Aurinia Pharmaceuticals Inc is higher than it is for about merely 8.5% of US stocks. With a price/sales ratio of 31.41, Aurinia Pharmaceuticals Inc has a higher such ratio than 92.58% of stocks in our set. Aurinia Pharmaceuticals Inc. (AUPH) latest earnings report: revenue, EPS, surprise, history, news and analysis.

zagreb stock exchange conference 2020 Gft global forex trading · Foreign currency symbols on keyboard · Stellar lumen price forecast. Recent Reviews. Bottom up top down stock picking · Auph stock options · Lcc coin wallet · Forex advisor

Aurinia Pharmaceuticals Inc (AUPH:NMQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and On the 22nd January of 2021, the drug got FDA approved PLUS a patent until 2037. But this time, it was different.

Today, the company has a high of $17.30 and a low of $16.83. The company has a market cap of $1.91 billion with a 52-week high of $21.93 and a 52-week low of $3.52.